incorrect... Sept 2022 Illuccix is the only PSMA-targeting PET agent approved and available in Australia for the diagnostic imaging of men with prostate cancer.
looks like kyahn wiiliamson svp communications disagrees with you too
incorrect... Sept 2022 Illuccix is the only PSMA-targeting PET...
Add TLX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$15.24 |
Change
0.440(2.97%) |
Mkt cap ! $5.036B | |||
| Open | High | Low | Value | Volume |
| $14.71 | $15.24 | $14.61 | $17.69M | 1.179M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2333 | $15.15 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $15.25 | 10000 | 2 |
View Market Depth
| Last trade - 16.10pm 03/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$15.21 |
Change
0.440 ( 2.60 %) |
||||
| Open | High | Low | Volume | ||
| $14.73 | $15.24 | $14.62 | 327752 | ||
| Last updated 15.59pm 03/05/2024 ? | |||||
| TLX (ASX) Chart |